Identitet

CID 11361973

Nije navedeno · C17H28N2O5

01Identitet

Lazychem IDLC-46175
CAS RNNije navedeno
PubChem CID11361973
Molecular formulaC17H28N2O5
Molecular weight340.4 g/mol
IUPAC name(3aR,4R,6S,6aS)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pentan-3-yl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,2]oxazole-6-carboxylic acid
InChIKeyXVJTUDPXKCBNKX-FMCLSXCISA-N

02Struktura i stereokemija

2D structurePubChem CID 11361973
Two-dimensional chemical structure of CID 11361973
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 2 rings, includes aliphatic carbon, has 4 defined stereocentres. These statements are calculated from the published structure string.

Defined stereocentres4
Ring count2
Secondary amines0
Tertiary amines0
SMILESCCC(CC)C1=NO[C@H]2[C@@H]1[C@@H](C[C@@H]2C(=O)O)NC(=O)OC(C)(C)C
InChINije navedeno

03Stereochemistry

The published structure contains 4 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres4Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 16Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status u Indiji

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nazivi i povezanosti

API i matični lijek

Nije navedeno

Nazivi i povezanosti

    Nečistoće i srodni spojevi

      06Izvori